Nicolás Martínez-Calle on Muck Rack

Nicolás Martínez-Calle

As seen in: Color Research & Application
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Nicolás

Contact Nicolás, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Advances in treatment of elderly primary central nervous system lymphoma

|
By Nicolás Martínez-Calle, Lisa Isbell, Kate Cwynarski, Elisabeth Schorb
| Wiley Online Library
Review Nicolas Martinez-Calle, Corresponding Author n.martinez-calle@nhs.net orcid.org/0000-0002-5184-9464 Clinical Haematology Department, Nottingham University Hospitals NHS Trust, Nottingham, UK Correspondence: Nicolas Martinez-Calle, Clinical Haematology Department, Nottingham University Hospitals NHS Trust, Nottingham NG9 1PB, UK. E-mail: n.martinez-calle@nhs.net Search for more papers by this author Lisa K.
Open in Who Shared Issue with article?

First-line use of rituximab correlates with increased overall survival in late post-transplant lymphoproliferative disorders: retrospective, single-centre study - Martínez-Calle - 2016 - European Journal of Haematology - Wiley Online Library

|
By Angel Panizo, Felipe Prosper, Ramón Lecumberri, Nicolás Martínez-Calle, Ana Alfonso, José Rifón, Ignacio Herrero, Pedro Errasti, Gregorio Rábago, Juana Merino, Javier Pardo , Ricardo García-Muñoz, Carlos Panizo
| Color Research & Application
This retrospective study evaluates the impact of rituximab on PTLD response and survival in a single-centre cohort. PTLD cases between 1984 and 2009, including heart, kidney, liver and lung transplant recipients, were included. Survival was analysed taking into account the type of PTLD (monomorphic vs. polymorphic), EBV infection status, IPI score, Ann Arbor stage and use of rituximab. Among 1335 transplanted patients, 24 developed PTLD.
Open in Who Shared Issue with article?
See all 2 articles

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Get in touch with Nicolás

Contact Nicolás, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified